668
Views
8
CrossRef citations to date
0
Altmetric
Laboratory Study

Gold Nanoparticle as an Alternative Tool for Urine Microalbumin Test: The First World Report

, &
Pages 1047-1048 | Published online: 07 Jul 2009

REFERENCES

  • Hindmarsh JT. Microalbuminuria. Clin Lab Med. 1988; 8: 611–616
  • Chiarelli F, Verrotti A, Mohn A, Morgese G. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: Therapeutic implications. Ann Med. 1997; 29: 439–445
  • Mogensen CE. Preventing end-stage renal disease. Diabet Med 1998; 15(Suppl. 4)S51–S56
  • Schwab SJ, Dunn FL, Feinglos MN. Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis. Diabetes Care. 1992; 15: 1581–1584
  • Kin PT, Wee A, Dan L, Guo J. Diagnostic test—O & G / Pregnancy. MIMS Medex 971st, PT Kin, A Wee, L Dan, J Guo. Medi & Media, Bangkok 1997; 145–146
  • Frenkell AI, Nemzer S, Pister I, Soussan L, Harris T, Sun Y, Rafailovich MH. Size-controlled synthesis and characterization of thiol-stabilized gold nanoparticles. J Chem Phys. 2005; 123: 184701
  • Airoldi G, Campanini M. Microalbuminuria: Theoretical bases and new applications. Recenti Prog Med. 1993; 84: 210–224
  • Service RF. Nanotechnology: Color-changing nanoparticles offer a golden ruler for molecules. Science. 2005; 308: 1099

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.